BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17972624)

  • 1. Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure.
    Chen PL; Day YJ; Su BC; Lee PC; Chen CY
    Acta Anaesthesiol Taiwan; 2007 Sep; 45(3):189-93. PubMed ID: 17972624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The severity of sevoflurane-induced malignant hyperthermia.
    Migita T; Mukaida K; Kobayashi M; Hamada H; Kawamoto M
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):351-6. PubMed ID: 22092278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia.
    Bonciu M; de la Chapelle A; Delpech H; Depret T; Krivosic-Horber R; Aimé MR
    Paediatr Anaesth; 2007 Feb; 17(2):180-2. PubMed ID: 17238892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthetic drugs and onset of malignant hyperthermia.
    Visoiu M; Young MC; Wieland K; Brandom BW
    Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed onset of suspected malignant hyperthermia during sevoflurane anesthesia in an Afghan trauma patient: a case report.
    Banek R; Weatherwax J; Spence D; Perry S; Muldoon S; Capacchione J
    AANA J; 2013 Dec; 81(6):441-5. PubMed ID: 24597005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat episodes of severe muscle rigidity in a child receiving sevoflurane.
    Cohen IT; Kaplan R
    Paediatr Anaesth; 2006 Oct; 16(10):1077-9. PubMed ID: 16972840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia.
    Jonassen AA; Petersen AJ; Mohr S; Andersson C; Skattum J; Kvernebo K; Paulsen OG; Stokland O; Kirkebøen KA
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1062-5. PubMed ID: 15315628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
    Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR
    Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two pediatric cases of malignant hyperthermia caused by sevoflurane].
    Kinouchi K; Okawa M; Fukumitsu K; Tachibana K; Kitamura S; Taniguchi A
    Masui; 2001 Nov; 50(11):1232-5. PubMed ID: 11758332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected malignant hyperthermia during sevoflurane anesthesia.
    Hsu SC; Huang WT; Yeh HM; Hsieh AY
    J Chin Med Assoc; 2007 Nov; 70(11):507-10. PubMed ID: 18063506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in onset of porcine malignant hyperthermia.
    Gronert GA; Milde JH
    Anesth Analg; 1981 Jul; 60(7):499-503. PubMed ID: 7195665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
    Flick RP; Gleich SJ; Herr MM; Wedel DJ
    Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of malignant hyperthermia in which treatment was carried out smoothly].
    Morota T; Endo K; Furuta S; Obara S; Ohmuzo H; Kaneko T; Onuma T; Watanabe K
    Masui; 2007 Jul; 56(7):826-30. PubMed ID: 17633846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
    Burkman JM; Posner KL; Domino KB
    Anesthesiology; 2007 May; 106(5):901-6; quiz 1077-8. PubMed ID: 17457120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of malignant hyperthermia arising five hours after the beginning of anaesthesia with sevoflurane and after five uneventful surgical procedures].
    Barbier M; Lafaye AL; Guerin R; Viguier-Hourcastagnou L; Payen JF; Bazin JE
    Ann Fr Anesth Reanim; 2009 Nov; 28(11):983-7. PubMed ID: 19910153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced hyperthermia and rhabdomyolysis during the perioperative period: report of three patients.
    Vorrakitpokatorn P; Limsakul A
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S884-92. PubMed ID: 12452225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant hyperthermia and sevoflurane--a case report].
    Claussen D; Wuttig K; Freudenberg J; Claussen A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):641-4. PubMed ID: 9445566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
    Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J
    Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General anesthesia for dental treatment in a Williams syndrome patient with severe aortic and pulmonary valve stenosis: suspected episode of postoperatively malignant hyperthermia.
    Kohase H; Wakita R; Doi S; Umino M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):e17-20. PubMed ID: 17683962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.